We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Tapestry
TPR
$31.1B
| $11.5M | 0.06% |
403,489
+40,946
| +11% | +$1.37M |
|
|
TWTR
252
DELISTED
Twitter, Inc.
TWTR
| $11.3M | 0.06% |
257,168
+149,018
| +138% | +$6.07M |
|
253
MGIC Investment
MTG
$6.29B
| $11.3M | 0.06% |
878,230
+562,235
| +178% | +$7.87M |
|
254
Corteva
CTVA
$50.4B
| $11.2M | 0.06% |
196,405
-18,203
| -8% | -$1.06M |
|
|
SWAV
255
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $11.2M | 0.06% |
40,289
+26,869
| +200% | +$6.83M |
|
256
Fortive
FTV
$18.6B
| $11.1M | 0.06% |
252,406
-86,654
| -26% | -$4.05M |
|
257
CMS Energy
CMS
$22B
| $11.1M | 0.06% |
190,239
-25,913
| -12% | -$1.74M |
|
258
Nexstar Media Group
NXST
$5.7B
| $11.1M | 0.06% |
66,385
-154,064
| -70% | -$28.6M |
|
259
Universal Display
OLED
$4.23B
| $10.9M | 0.06% |
115,964
-15,151
| -12% | -$1.68M |
|
260
Quest Diagnostics
DGX
$26.2B
| $10.8M | 0.06% |
87,957
+24,573
| +39% | +$3.24M |
|
261
Allison Transmission
ALSN
$10.2B
| $10.8M | 0.06% |
319,607
-20,887
| -6% | -$781K |
|
262
Synopsys
SNPS
$79B
| $10.8M | 0.06% |
35,222
+23,337
| +196% | +$7.9M |
|
263
McDonald's
MCD
$195B
| $10.7M | 0.06% |
46,482
-10,850
| -19% | -$2.77M |
|
|
EA
264
DELISTED
Electronic Arts
EA
| $10.7M | 0.06% |
+92,626
| New | +$11.7M |
|
|
CMA
265
DELISTED
Comerica
CMA
| $10.6M | 0.05% |
148,497
+38,198
| +35% | +$3.01M |
|
266
Vontier
VNT
$4.52B
| $10.5M | 0.05% |
630,611
-323,104
| -34% | -$7.2M |
|
267
Fair Isaac
FICO
$22.6B
| $10.5M | 0.05% |
25,491
-639
| -2% | -$290K |
|
268
Ashland
ASH
$3.42B
| $10.4M | 0.05% |
109,727
-11,030
| -9% | -$1.12M |
|
269
Snowflake
SNOW
$115B
| $10.2M | 0.05% |
60,294
-52,814
| -47% | -$8.74M |
|
270
PNC Financial Services
PNC
$102B
| $10.2M | 0.05% |
68,556
+10,181
| +17% | +$1.65M |
|
271
United Therapeutics
UTHR
$21.9B
| $10.2M | 0.05% |
+48,812
| New | +$10.9M |
|
272
Pinnacle Financial Partners Inc
PNFP
$16.1B
| $10.1M | 0.05% |
124,928
+18,098
| +17% | +$1.45M |
|
273
Booz Allen Hamilton
BAH
$9.43B
| $10.1M | 0.05% |
109,294
-67,404
| -38% | -$6.39M |
|
274
Duke Energy
DUK
$96.3B
| $10M | 0.05% |
107,478
-22,022
| -17% | -$2.37M |
|
275
Sherwin-Williams
SHW
$87.4B
| $9.93M | 0.05% |
48,519
+4,141
| +9% | +$981K |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.